SCHEMBL23146325

SCHEMBL23146325

CCOC(=O)c1cnc(OCCOC)s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 3/20 0.51
DBF4 Q9UBU7 3/20 0.51
ALDH1A1 P00352 3/20 0.41
GAA P10253 3/20 0.41
RAB9A P51151 1/20 0.41
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
P2RX3 P56373 4/20 0.39
HSD17B10 Q99714 3/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 2/20 0.37
MAPT P10636 2/20 0.37
OGA O60502 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 2/20 0.36
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18418893 0.91 TSHR (0.44) CDC7DBF4ALDH1A1GAARAB9A
SCHEMBL23179999 0.84 CDC7 (0.56) CDC7DBF4ALDH1A1GAARAB9A
SCHEMBL18418895 0.81 HCAR2 (0.49) RAB9AP2RX3MAPT
SCHEMBL23146427 0.78 CDC7 (0.52) CDC7DBF4ALDH1A1GAARAB9A
SCHEMBL19764487 0.76 CDC7 (0.43) CDC7DBF4ALDH1A1GAARAB9A
SCHEMBL286068 0.76 CDC7 (0.60) CDC7DBF4ALDH1A1GAAHDAC3
SCHEMBL16933028 0.76 CDC7 (0.60) CDC7DBF4ALDH1A1GAAHDAC3
SCHEMBL11705050 0.76 CDC7 (0.54) CDC7DBF4ALDH1A1GAARAB9A
SCHEMBL274346 0.74 CDC7 (0.59) CDC7DBF4ALDH1A1GAAHDAC3
SCHEMBL6476591 0.74 CDC7 (0.59) CDC7DBF4ALDH1A1GAAHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220396586-A1 THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC (US) 2022-12-15 US disclosed
US-20220396586-A1 THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC (US) 2022-12-15 US disclosed
EP-4034106-A1 THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS The Global Alliance for TB Drug Development, Inc. (US) 2022-08-03 EP disclosed
CN-114746089-A Thiazolecarboxamide compounds and their use for the treatment of mycobacterial infections 结核病药物开发全球联盟公司 2022-07-12 CN disclosed
WO-2021062318-A1 THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) 2021-04-01 WO disclosed
WO-2021062318-A1 THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) 2021-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220396586-A1 THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS GOT2, ABAT, SDHA CDC7 2629/4885DBF4 2720/4885ALDH1A1 416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.